Pfizer buying spree continues with $5.4B hematology deal
The pharmaceutical giant continues to invest some of the cash influx reaped during the COVID-19 pandemic.
The pharmaceutical giant continues to invest some of the cash influx reaped during the COVID-19 pandemic.